NicOx, Merck amend NO deal

NicOx S.A. (Euronext:COX) and Merck & Co. Inc. (NYSE:MRK) said they will use a new approach for nitric oxide (NO) donation as part of a revised 2006 deal after discontinuing further development of the deal's original NO-donating compounds. The companies said Phase I data of the compounds, which were focused on hypertension, did not meet the criteria to move into Phase II testing. ...